| Literature DB >> 27391024 |
Derek M Foster, Luke G Martin, Mark G Papich.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0149100.].Entities:
Year: 2016 PMID: 27391024 PMCID: PMC4938403 DOI: 10.1371/journal.pone.0159219
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Plasma, Insterstitial Fluid (ISF), and Pulmonary Epithelial Lining Fluid (PELF) Pharmacokinetics after Administration of 2.5 mg/kg of Tulathromycin to Calves.
| Plasma | ISF | PELF | |||||
|---|---|---|---|---|---|---|---|
| Parameter | Units | Mean | CV% | Mean | CV% | Mean | CV% |
| AUC % extrapolated | % | 8.25 | 37.96 | 15.88 | 86.29 | 24.9 | 54.1 |
| AUC (0 to infinity) | hr*μg/mL | 14.48 | 28.61 | 8.60 | 7.50 | 119.90 | 27.6 |
| AUC (0 to Cn) | hr*μg/mL | 13.23 | 26.62 | 5.54 | 39.75 | 87.64 | 21.7 |
| Cmax | μg/mL | 1.82 | 82.28 | 0.042 | 50.73 | 0.87 | 29.5 |
| Ke T ½ | hr | 81.24 | 38.27 | 65.88 | 73.52 | 153.1 | 52.5 |
| Ke | 1/hr | 0.01 | 51.71 | 0.01 | 59.13 | 0.0 | 45.3 |
| MRT | hr | 101.33 | 14.53 | 171.46 | 35.69 | 220.7 | 42.7 |
| Tmax | hr | 0.54 | 45.38 | 168.00 | 52.68 | 15.0 | 65.7 |
| Tissue Penetration | % | 44 | 51.93 | 910 | 44.6 | ||
AUC, Area-under-the-curve, from zero to the last time point (Cn), and from 0 to infinity; AUC % extrapolated is the percent extrapolated to infinity. Cmax, peak (maximum) concentration; Tmax, time to peak concentration; Penetration factor, ratio of AUC values of tissue site: plasma; Ke, elimination (terminal) rate, and associated half-life, T½; MRT, mean residence time.